美国 · 财经报刊 · Investor's Business Daily
How Gilead, Which Just Hit A Record, Notched Its Best Sales Growth In A Decade
Gilead Sciences crushed Wall Street's sales expectations on the back of its HIV treatments and cancer drug Trodelvy. The post How Gilead, Which Just Hit A Record, Notched Its Best…
在 Investor's Business Daily 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.investors.com)
